Something is happening in life sciences in Atlantic Canada, which was far and away the most exciting segment of the innovation economy in the first quarter of 2019.
In the three months to March 31, biology-focused companies raised $74.3 million in equity funding, filed a prospectus for a stock market listing and announced a $145 million plant expansion. Behind those headline items, things are happening that should support the long-term outlook for the sector.
